Screening of Prediabetes in End Stage Renal Disease on Dialysis
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 262
- 试验地点
- 2
- 主要终点
- The prevalence of prediabetes in the End Stage Renal Disease (ESRD) on dialysis cohort.
研究概览
简要总结
Prediabetes is a highly prevalent condition, affecting about one-third of adults in the United States Patients with prediabetes have an increased risk for diabetes, with 2% to 10% progressing to diabetes each yea Although prediabetes is frequently considered an intermediary stage in the progression between normoglycemia and diabetes, many individuals may have prediabetes for several years, while some may never progress.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •End stage renal disease on dialysis patients aged ≥ 18 years old.
排除标准
- •Patients previously diagnosed with prediabetes.
- •Patients previously diagnosed with diabetes mellitus.
- •Acute Medical Status :Hospitalized patients.
- •Physiological States: Pregnant females.Lactating females.
- •Specific Comorbidities & Conditions: Polycystic kidney disease.
- •New York Heart Association (NYHA) class III or IV heart failure.
- •Known liver cirrhosis. or HIV/AIDS.
- •Renal cancer.
- •Active immunosuppression. or Recent chemotherapy or immunosuppressive therapy.
- •History of organ transplantation.
结局指标
主要结局
The prevalence of prediabetes in the End Stage Renal Disease (ESRD) on dialysis cohort.
时间窗: "The time frame for measurement of the primary outcome (prevalence of prediabetes) with all diagnostic measurements (Fasting Plasma Glucose mg/dl) performed once per participant at the time of their inclusion in the study."
次要结局
未报告次要终点
研究者
Hany Ahmed Mohamed
lecturer of internal medicine
Sohag University